サマリー

市場分析と洞察。世界と中国のドブタミン市場
当レポートでは、世界と中国のDobutamine市場に焦点を当てています。
2020年の世界のDobutamine市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで、2027年末にXX百万米ドルに達すると予想されています。中国のDobutamine市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界のドブタミンの範囲と市場規模
ドブタミン市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のDobutamine市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の売上高と予測に焦点を当てています。
中国市場については、2016-2027年のドブタミンの市場規模を、プレイヤー別、タイプ別、アプリケーション別に取り上げています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
注射 200mg
注入250mg

用途別セグメント
慢性心不全
心筋梗塞
術後低血圧
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
アイバックス・ファーマシューティカルズ
フィジシャンズ トータル ケア
バクスター・ヘルスケア
サノフィ
テバ・カナダ
ファイザー
ベッドフォード・ラボラトリーズ
ノバルティス
ステリマックス
テリジェント

ページTOPに戻る

目次

1 Study Coverage
1.1 Dobutamine Product Introduction
1.2 Market by Type
1.2.1 Global Dobutamine Market Size Growth Rate by Type
1.2.2 Injection 200mg
1.2.3 Injection 250mg
1.3 Market by Application
1.3.1 Global Dobutamine Market Size Growth Rate by Application
1.3.2 Chronic Heart Failure
1.3.3 Myocardial Infarction
1.3.4 Postoperative Hypotension
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Dobutamine Market Size, Estimates and Forecasts
2.1.1 Global Dobutamine Revenue 2016-2027
2.1.2 Global Dobutamine Sales 2016-2027
2.2 Global Dobutamine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Dobutamine Historical Market Size by Region (2016-2021)
2.3.1 Global Dobutamine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Dobutamine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Dobutamine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Dobutamine Sales Forecast by Region (2022-2027)
2.4.2 Global Dobutamine Revenue Forecast by Region (2022-2027)

3 Global Dobutamine Competitor Landscape by Players
3.1 Global Top Dobutamine Manufacturers by Sales
3.1.1 Global Dobutamine Sales by Manufacturer (2016-2021)
3.1.2 Global Dobutamine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Dobutamine Manufacturers by Revenue
3.2.1 Key Dobutamine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Dobutamine Revenue by Manufacturers (2016-2021)
3.2.3 Global Dobutamine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Dobutamine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Dobutamine Revenue in 2020
3.2.6 Global Dobutamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dobutamine Price by Manufacturers
3.4 Global Dobutamine Manufacturing Base Distribution, Product Types
3.4.1 Dobutamine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dobutamine Product Type
3.4.3 Date of International Manufacturers Enter into Dobutamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Dobutamine Market Size by Type (2016-2021)
4.1.1 Global Dobutamine Sales by Type (2016-2021)
4.1.2 Global Dobutamine Revenue by Type (2016-2021)
4.1.3 Dobutamine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Dobutamine Market Size Forecast by Type (2022-2027)
4.2.1 Global Dobutamine Sales Forecast by Type (2022-2027)
4.2.2 Global Dobutamine Revenue Forecast by Type (2022-2027)
4.2.3 Dobutamine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Dobutamine Market Size by Application (2016-2021)
5.1.1 Global Dobutamine Sales by Application (2016-2021)
5.1.2 Global Dobutamine Revenue by Application (2016-2021)
5.1.3 Dobutamine Price by Application (2016-2021)
5.2 Dobutamine Market Size Forecast by Application (2022-2027)
5.2.1 Global Dobutamine Sales Forecast by Application (2022-2027)
5.2.2 Global Dobutamine Revenue Forecast by Application (2022-2027)
5.2.3 Global Dobutamine Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Dobutamine Market Size YoY Growth 2016-2027
6.1.1 China Dobutamine Sales YoY Growth 2016-2027
6.1.2 China Dobutamine Revenue YoY Growth 2016-2027
6.1.3 China Dobutamine Market Share in Global Market 2016-2027
6.2 China Dobutamine Market Size by Players (International and Local Players)
6.2.1 China Top Dobutamine Players by Sales (2016-2021)
6.2.2 China Top Dobutamine Players by Revenue (2016-2021)
6.3 China Dobutamine Historic Market Review by Type (2016-2021)
6.3.1 China Dobutamine Sales Market Share by Type (2016-2021)
6.3.2 China Dobutamine Revenue Market Share by Type (2016-2021)
6.3.3 China Dobutamine Price by Type (2016-2021)
6.4 China Dobutamine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Dobutamine Sales Forecast by Type (2022-2027)
6.4.2 China Dobutamine Revenue Forecast by Type (2022-2027)
6.4.3 China Dobutamine Price Forecast by Type (2022-2027)
6.5 China Dobutamine Historic Market Review by Application (2016-2021)
6.5.1 China Dobutamine Sales Market Share by Application (2016-2021)
6.5.2 China Dobutamine Revenue Market Share by Application (2016-2021)
6.5.3 China Dobutamine Price by Application (2016-2021)
6.6 China Dobutamine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Dobutamine Sales Forecast by Application (2022-2027)
6.6.2 China Dobutamine Revenue Forecast by Application (2022-2027)
6.6.3 China Dobutamine Price Forecast by Application (2022-2027)

7 North America
7.1 North America Dobutamine Market Size YoY Growth 2016-2027
7.2 North America Dobutamine Market Facts & Figures by Country
7.2.1 North America Dobutamine Sales by Country (2016-2021)
7.2.2 North America Dobutamine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Dobutamine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Dobutamine Market Facts & Figures by Region
8.2.1 Asia Pacific Dobutamine Sales by Region (2016-2021)
8.2.2 Asia Pacific Dobutamine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Dobutamine Market Size YoY Growth 2016-2027
9.2 Europe Dobutamine Market Facts & Figures by Country
9.2.1 Europe Dobutamine Sales by Country (2016-2021)
9.2.2 Europe Dobutamine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Dobutamine Market Size YoY Growth 2016-2027
10.2 Latin America Dobutamine Market Facts & Figures by Country
10.2.1 Latin America Dobutamine Sales by Country (2016-2021)
10.2.2 Latin America Dobutamine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Dobutamine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Dobutamine Market Facts & Figures by Country
11.2.1 Middle East and Africa Dobutamine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Dobutamine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Ivax Pharmaceuticals 
12.1.1 Ivax Pharmaceuticals  Corporation Information
12.1.2 Ivax Pharmaceuticals  Description and Business Overview
12.1.3 Ivax Pharmaceuticals  Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Ivax Pharmaceuticals  Dobutamine Products Offered
12.1.5 Ivax Pharmaceuticals  Recent Development
12.2 Physicians Total Care
12.2.1 Physicians Total Care Corporation Information
12.2.2 Physicians Total Care Description and Business Overview
12.2.3 Physicians Total Care Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Physicians Total Care Dobutamine Products Offered
12.2.5 Physicians Total Care Recent Development
12.3 Baxter Healthcare 
12.3.1 Baxter Healthcare  Corporation Information
12.3.2 Baxter Healthcare  Description and Business Overview
12.3.3 Baxter Healthcare  Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Baxter Healthcare  Dobutamine Products Offered
12.3.5 Baxter Healthcare  Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Dobutamine Products Offered
12.4.5 Sanofi Recent Development
12.5 Teva Canada
12.5.1 Teva Canada Corporation Information
12.5.2 Teva Canada Description and Business Overview
12.5.3 Teva Canada Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Canada Dobutamine Products Offered
12.5.5 Teva Canada Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Dobutamine Products Offered
12.6.5 Pfizer Recent Development
12.7 Bedford Laboratories
12.7.1 Bedford Laboratories Corporation Information
12.7.2 Bedford Laboratories Description and Business Overview
12.7.3 Bedford Laboratories Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bedford Laboratories Dobutamine Products Offered
12.7.5 Bedford Laboratories Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Description and Business Overview
12.8.3 Novartis Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Dobutamine Products Offered
12.8.5 Novartis Recent Development
12.9 Sterimax
12.9.1 Sterimax Corporation Information
12.9.2 Sterimax Description and Business Overview
12.9.3 Sterimax Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sterimax Dobutamine Products Offered
12.9.5 Sterimax Recent Development
12.10 Teligent
12.10.1 Teligent Corporation Information
12.10.2 Teligent Description and Business Overview
12.10.3 Teligent Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teligent Dobutamine Products Offered
12.10.5 Teligent Recent Development
12.11 Ivax Pharmaceuticals 
12.11.1 Ivax Pharmaceuticals  Corporation Information
12.11.2 Ivax Pharmaceuticals  Description and Business Overview
12.11.3 Ivax Pharmaceuticals  Dobutamine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Ivax Pharmaceuticals  Dobutamine Products Offered
12.11.5 Ivax Pharmaceuticals  Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Dobutamine Industry Trends
13.2 Dobutamine Market Drivers
13.3 Dobutamine Market Challenges
13.4 Dobutamine Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dobutamine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer